Clovis Oncology Announces 2M Share Offering by Selling Stockholders

Loading...
Loading...
Clovis Oncology
CLVS
announced today that certain selling stockholders have commenced an underwritten public offering of 2,000,000 shares of the Company's common stock which they recently acquired as consideration in connection with the Company's acquisition of EOS (Ethical Oncology Science) S.p.A. All net proceeds from the sale of the common stock will be received by the selling stockholders. The Company will not receive any of the proceeds, and the total number of shares of its outstanding common stock will not change as a result of the offering. J. P. Morgan Securities LLC is acting as the sole manager for the offering. In addition, the selling stockholders intend to grant J. P.
See full press release
Posted In: NewsGuidanceOfferingsGlobal
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...